Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes
Mechanisms of Action of Hydroxychloroquine in Reducing Risk of Type 2 Diabetes
Status: Enrolling
Updated:  1/28/2016
University of Pittsburgh, Montefiore Hospital
mi
from
Pittsburgh, PA
Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes
Mechanisms of Action of Hydroxychloroquine in Reducing Risk of Type 2 Diabetes
Status: Enrolling
Updated: 1/28/2016
University of Pittsburgh, Montefiore Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The VALDIATE-D Study
Evaluating Hormonal Mechanisms for Vitamin D Receptor Agonist Therapy in Diabetes: The VALIDATE-D Study
Status: Enrolling
Updated:  2/1/2016
Brigham and Women's Hosp
mi
from
Boston, MA
The VALDIATE-D Study
Evaluating Hormonal Mechanisms for Vitamin D Receptor Agonist Therapy in Diabetes: The VALIDATE-D Study
Status: Enrolling
Updated: 2/1/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated:  2/1/2016
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated: 2/1/2016
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated:  2/1/2016
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated: 2/1/2016
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated:  2/1/2016
Miami VA
mi
from
Miami, FL
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated: 2/1/2016
Miami VA
mi
from
Miami, FL
Click here to add this to my saved trials
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated:  2/1/2016
South Shore Hospital
mi
from
Weymouth, MA
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone
Status: Enrolling
Updated: 2/1/2016
South Shore Hospital
mi
from
Weymouth, MA
Click here to add this to my saved trials
Gestational Diabetes Diagnostic Methods
GD2M Study:Gestational Diabetes Diagnostic Methods
Status: Enrolling
Updated:  2/2/2016
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Gestational Diabetes Diagnostic Methods
GD2M Study:Gestational Diabetes Diagnostic Methods
Status: Enrolling
Updated: 2/2/2016
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Status: Enrolling
Updated:  2/2/2016
Harvest Family Health Center
mi
from
Elm City, NC
Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Status: Enrolling
Updated: 2/2/2016
Harvest Family Health Center
mi
from
Elm City, NC
Click here to add this to my saved trials
Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Status: Enrolling
Updated:  2/2/2016
Freedom Hill Community Health Center
mi
from
Tarboro, NC
Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Status: Enrolling
Updated: 2/2/2016
Freedom Hill Community Health Center
mi
from
Tarboro, NC
Click here to add this to my saved trials
Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Status: Enrolling
Updated:  2/2/2016
Wilson Community Health Center
mi
from
Wilson, NC
Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Status: Enrolling
Updated: 2/2/2016
Wilson Community Health Center
mi
from
Wilson, NC
Click here to add this to my saved trials
Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes
Effects of Pulsatile Intravenous Insulin on Brittle Diabetes and Glucose Control
Status: Enrolling
Updated:  2/2/2016
Florida Atlantic University
mi
from
Boca Raton, FL
Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes
Effects of Pulsatile Intravenous Insulin on Brittle Diabetes and Glucose Control
Status: Enrolling
Updated: 2/2/2016
Florida Atlantic University
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours
A Feasibility Study to Assess Critical Aspects of FAS Performance and Safety Over Several Hours
Status: Enrolling
Updated:  2/3/2016
Practice of Eric Orzeck, MD
mi
from
Houston, TX
A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours
A Feasibility Study to Assess Critical Aspects of FAS Performance and Safety Over Several Hours
Status: Enrolling
Updated: 2/3/2016
Practice of Eric Orzeck, MD
mi
from
Houston, TX
Click here to add this to my saved trials
Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults
Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overweight/Obese Adults With Normal or Impaired Glucose Tolerance or Type 2 Diabetes
Status: Enrolling
Updated:  2/4/2016
Purdue University
mi
from
West Lafayette, IN
Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults
Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overweight/Obese Adults With Normal or Impaired Glucose Tolerance or Type 2 Diabetes
Status: Enrolling
Updated: 2/4/2016
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.
A Phase 1, Randomized, Open-label, Cross-over, Single-day Study Of Pf-04937319 To Characterize Relative Bioavailability, Tolerability, And Pharmacodynamics Of Four Oral Formulations In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  2/4/2016
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.
A Phase 1, Randomized, Open-label, Cross-over, Single-day Study Of Pf-04937319 To Characterize Relative Bioavailability, Tolerability, And Pharmacodynamics Of Four Oral Formulations In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 2/4/2016
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.
A Phase 1, Randomized, Open-label, Cross-over, Single-day Study Of Pf-04937319 To Characterize Relative Bioavailability, Tolerability, And Pharmacodynamics Of Four Oral Formulations In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  2/4/2016
High Point Clinical Trials Center
mi
from
High Point, NC
Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.
A Phase 1, Randomized, Open-label, Cross-over, Single-day Study Of Pf-04937319 To Characterize Relative Bioavailability, Tolerability, And Pharmacodynamics Of Four Oral Formulations In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 2/4/2016
High Point Clinical Trials Center
mi
from
High Point, NC
Click here to add this to my saved trials
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Status: Enrolling
Updated:  2/4/2016
Cardiovascular Genetics, University of Utah
mi
from
Salt Lake City, UT
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Status: Enrolling
Updated: 2/4/2016
Cardiovascular Genetics, University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Immunosuppressive Medications for Previous Participants in Clinical Trial NIS01 (ITN005CT, NCT00014911)
Status: Enrolling
Updated:  2/5/2016
University of Miami
mi
from
Miami, FL
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Immunosuppressive Medications for Previous Participants in Clinical Trial NIS01 (ITN005CT, NCT00014911)
Status: Enrolling
Updated: 2/5/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Immunosuppressive Medications for Previous Participants in Clinical Trial NIS01 (ITN005CT, NCT00014911)
Status: Enrolling
Updated:  2/5/2016
Massachusetts General Hospital
mi
from
Boston, MA
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Immunosuppressive Medications for Previous Participants in Clinical Trial NIS01 (ITN005CT, NCT00014911)
Status: Enrolling
Updated: 2/5/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Immunosuppressive Medications for Previous Participants in Clinical Trial NIS01 (ITN005CT, NCT00014911)
Status: Enrolling
Updated:  2/5/2016
Washington University
mi
from
St. Louis, MO
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Immunosuppressive Medications for Previous Participants in Clinical Trial NIS01 (ITN005CT, NCT00014911)
Status: Enrolling
Updated: 2/5/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Changing the Healthcare Delivery Model
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Status: Enrolling
Updated:  2/8/2016
Howard University
mi
from
Washington,
Changing the Healthcare Delivery Model
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Status: Enrolling
Updated: 2/8/2016
Howard University
mi
from
Washington,
Click here to add this to my saved trials
Changing the Healthcare Delivery Model
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Status: Enrolling
Updated:  2/8/2016
Medical Faculty Assoc Inc, GWUniv
mi
from
Washington,
Changing the Healthcare Delivery Model
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Status: Enrolling
Updated: 2/8/2016
Medical Faculty Assoc Inc, GWUniv
mi
from
Washington,
Click here to add this to my saved trials
Changing the Healthcare Delivery Model
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Status: Enrolling
Updated:  2/8/2016
MedStar Washington Hospital Center
mi
from
Washington,
Changing the Healthcare Delivery Model
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Status: Enrolling
Updated: 2/8/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Birmingham, AL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Neufeld Medical Group
mi
from
Los Angeles, CA
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Neufeld Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Sacramento, CA
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
San Diego, CA
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Ventura, CA
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Ventura, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Aurora, CO
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Aurora, CO
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Boca Raton, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Pediatric Endocrinology
mi
from
Hollywood, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Pediatric Endocrinology
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Miami, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Miami, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Miami, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Orlando, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Orlando, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Wright, Nancy
mi
from
Tallahassee, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Wright, Nancy
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Tampa, FL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Columbus Research Foundation
mi
from
Columbus, GA
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Columbus Research Foundation
mi
from
Columbus, GA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Chicago, IL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
St. James Ctr For Diabetes
mi
from
Olympia Fields, IL
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
St. James Ctr For Diabetes
mi
from
Olympia Fields, IL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
New Orleans, LA
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Alzohaili Medical Consultants
mi
from
Dearborn, MI
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Alzohaili Medical Consultants
mi
from
Dearborn, MI
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Saint Louis, MO
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Billings, MT
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Billings, MT
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Hackensack, NJ
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
UMDNJ-RWJ Medical School
mi
from
New Brunswick, NJ
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
UMDNJ-RWJ Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Buffalo, NY
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Winthrop University Hospital
mi
from
Mineola, NY
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Greenville, NC
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Greenville, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Akron, OH
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Akron, OH
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Athens, OH
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients With Type 2 Diabetes
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Athens, OH
Click here to add this to my saved trials